In a study by Del Re et al., PD-L1 mRNA expression was evaluated in circulating exosomes from 18 patients with melanoma or 8 patients with NSCLC, who were treated with pembrolizumab and nivolumab. The gene discussed is CD274; the disease is non-small cell lung carcinoma.